ライフサイエンスコーパス: Meniere's disease

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 cal specimens from patients with intractable Meniere's disease.

2 an vestibular macula utricle from normal and Meniere's disease.

3 ffort to identify genetic causes of familial Meniere's disease.

4 ated vertigo), bilateral vestibulopathy, and Meniere's disease.

5 s hearing involvement may be misdiagnosed as Meniere's disease.

6 gy as well as the diagnosis and treatment of Meniere's disease.

7 he most debilitating symptom associated with Meniere's disease.

8 sac may be implicated in the pathogenesis of Meniere's disease.

9 will help define the role of vasopressin in Meniere's disease.

10 ablative, effective treatment for refractory Meniere's disease.

11 Among patients with Meniere's disease, 5 of 9 had improvement or resolution

12 ntly no cure, more than 85% of patients with Meniere's disease are helped by either changes in lifest

13 Although debilitating syndromes like Meniere's disease are in part characterized by recurrent

14 Initial management of Meniere's disease can involve a low-salt diet and a diur

15 Meniere's disease is a chronic illness that affects a su

16 Meniere's disease is characterised by severe vertigo att

17 Meniere's disease is characterized by spontaneous attack

18 Meniere's disease (MD) is a chronic disorder of the inne

19 Meniere's Disease (MD) is a complex disorder associated

20 cimens of three different types of patients (Meniere's disease, normal controls, and other otopatholo

21 micin, the standard treatment for refractory Meniere's disease, reduces vertigo, but damages vestibul

22 Meniere's disease specimens revealed differential ultras

23 uch as sudden sensorineural hearing loss and Meniere's disease that are elicited by pathogens and pro

24 aged 18-70 years with refractory unilateral Meniere's disease were enrolled at Charing Cross Hospita

25 2009, and April 15, 2013, 256 patients with Meniere's disease were screened, 60 of whom were enrolle

26 th bilateral IMCVDs or symptoms of bilateral Meniere's disease were treated with etanercept (25 mg tw

27 e GLAST immunoreactive area of patients with Meniere's disease when compared to that of patients with

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。